RosVivo Therapeutics
Myung Suk Song is on the Board of Directors at RosVivo Therapeutics. Myung is also the CEO of Nexturn Bioscience Co., Ltd.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
RosVivo Therapeutics
1 followers
RosVivo Therapeutics targets diseases with breakthrough therapies utilizing microRNA (miRNA) and small interfering-RNA (siRNA) drugs. They're using unique scientific insights to develop a new pipeline of first-in-class drugs and diagnostic tests. Their development programs focus on the leading T2D, obesity, and COVID-19 drug candidates.